Potential biomarkers for the clinical prognosis of severe dengue

• Main Authors: Mayara Marques Carneiro da Silva, Laura Helena Vega Gonzales Gil, Ernesto Torres de Azevedo Marques Junior, Carlos Eduardo Calzavara-Silva
• Format: Article
• Language: English
• Published: Instituto Oswaldo Cruz, Ministério da Saúde 2013-09-01
• Series: Memórias do Instituto Oswaldo Cruz.
• Subjects: dengue; biomarkers; apoptosis; innate immunity; quantitative real-time PCR
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762013000600755&lng=en&tlng=en

Currently, several assays can confirm acute dengue infection at the point-of-care. However, none of these assays can predict the severity of the disease symptoms. A prognosis test that predicts the likelihood of a dengue patient to develop a severe form of the disease could permit more efficient patient triage and treatment. We hypothesise that mRNA expression of apoptosis and innate immune response-related genes will be differentially regulated during the early stages of dengue and might predict the clinical outcome. Aiming to identify biomarkers for dengue prognosis, we extracted mRNA from the peripheral blood mononuclear cells of mild and severe dengue patients during the febrile stage of the disease to measure the expression levels of selected genes by quantitative polymerase chain reaction. The selected candidate biomarkers were previously identified by our group as differentially expressed in microarray studies. We verified that the mRNA coding for CFD, MAGED1, PSMB9, PRDX4 and FCGR3B were differentially expressed between patients who developed clinical symptoms associated with the mild type of dengue and patients who showed clinical symptoms associated with severe dengue. We suggest that this gene expression panel could putatively serve as biomarkers for the clinical prognosis of dengue haemorrhagic fever.